1. Complement Receptor 3 Pathway and NMDA Receptor 2B Subunit Involve Neuropathic Pain Associated with Spinal Cord Injury
- Author
-
Li Y, Fang SC, Zhou L, Mo XM, Guo HD, Deng YB, Yu HH, and Gong WY
- Subjects
spinal cord injury ,neuropathic pain ,complement receptor 3 ,complement component 3 ,nmda receptor 2b subunit ,Medicine (General) ,R5-920 - Abstract
Yong Li,1,* Sheng-Chun Fang,2,* Lan Zhou,1 Xue-Mei Mo,3 Hao-Dong Guo,3 Yan-Bo Deng,3 Hong-Hao Yu,1 Wei-Yi Gong3 1College of Biotechnology, Guilin Medical University, Guilin, Guangxi, 541100, People’s Republic of China; 2Department of Anesthesiology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430015, People’s Republic of China; 3Department of Pain Management, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, 541000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Hong-Hao Yu, College of Biotechnology, Guilin Medical University, Guilin, Guangxi, 541100, People’s Republic of China, Email geneyhh@126.com Wei-Yi Gong, Department of Pain Management, Affiliated Hospital of Guilin Medical University, Guilin, 541000, Guangxi, People’s Republic of China, Email 942261597@qq.comBackground: Neuropathic pain (NP) after spinal cord injury (SCI-evoked NP) is clinically challenging; the underlying mechanisms are not fully understood, leading to a lack of promising treatment options. NP occurs in only a subset of patients with SCI. The injured spinal cord exhibits a series of histopathological changes, and the complement system has been shown to play an important role in these processes. In addition, NMDA receptor subunit 2B (NR2B) is involved in the development and maintenance of NP. This preliminary study was performed to investigate the correlations of the complement receptor 3/complement component 3 (CR3/C3) pathway and NR2B with SCI-evoked NP.Methods: A trauma-induced SCI animal model was established and SCI-evoked NP was evaluated by behavioural analysis. Transcriptome analysis was performed to identify genes in the CR3/C3 pathway related to synaptic modification, while the expression and distribution of NR2B in the injured spinal cord, and the relation to NP, were examined by immunohistochemical analysis.Results: Nine of seventeen SCI rats (52.9%) developed NP. C3 mRNA expression was significantly decreased in SCI-evoked NP rats and significantly increased in the non-NP SCI rats. C1q mRNA and CR3 mRNA expression were significantly increased in all SCI rats, but higher levels of expression were observed in the non-NP SCI rats. NR2B mRNA expression was significantly increased in the SCI-evoked NP rats and significantly decreased in the non-NP SCI rats. In addition, significantly elevated expression of NR2B-positive cells was seen in lamina II of the superficial dorsal horn in SCI-evoked NP rats in comparison with non-NP SCI rats.Conclusion: NP occurred in only a subset of SCI rats, and the CR3/C3 pathway and NR2B were involved in SCI-evoked NP. Further studies are required to determine the mechanisms underlying the SCI-evoked NP associated with the CR3/C3 pathway and NR2B.Keywords: spinal cord injury, neuropathic pain, complement receptor 3, complement component 3, NMDA receptor 2B subunit
- Published
- 2022